Full results of the SURPASS-1 clinical trial were presented at the American Diabetes Association’s 81st Scientific Sessions.

"We are always looking for new ways to advance and improve patient care, and are proud to be the first center in the world to offer this novel imaging technology,” the specialist said. 

Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.

The analysis, published in European Heart Journal Open, also included a look at how COVID-19 may affect these numbers going forward. 

Researchers have developed a new risk score that outperforms previous techniques. 

Myocardial fibrosis was more common among people with a confirmed HIV diagnosis, the authors found.

Johnson & Johnson will pay New York State $230 million in a settlement over a lawsuit against the drug manufacturer for its role in the opioid epidemic. 

Three private law firms have agreed to represent the pediatric radiologist accusing Phoenix Children's of wrongful termination.